Page 10 - University of Texas Health Science Center at San Antonio

Cardiology

New treatment option shown for heart failure fluid overload

Higher doses of spironolactone, a diuretic (water pill), can prevent the need for dialysis in selected heart failure patients, a UT Health San Antonio study found. The aggressive approach relieved fluid overload safely and ...

Neuroscience

Novel therapy administered after TBI prevents brain damage

An experimental treatment given to mice after a traumatic brain injury (TBI) reduced damage almost to the levels of mice that never had a TBI, researchers at UT Health San Antonio reported. The study was published July 4 ...

Diseases, Conditions, Syndromes

Largest study of CTE finds it in 6% of subjects

Nearly 6% of athletes and non-athletes were found to have the neurodegenerative disorder chronic traumatic encephalopathy (CTE) in the largest, and broadest, study conducted of the disease to date. The findings were published ...

Cardiology

Team studies smarter automatic defibrillator

Thousands of patients with congestive heart failure benefit from automatic implantable cardiac defibrillators (AICDs) that deliver shocks to the heart to correct abnormal heart rhythms. These defibrillators improve survival ...

Oncology & Cancer

Do all chemotherapies have equal long-term heart risk?

In long-term survivors of childhood cancer, cardiovascular disease is a leading cause of early death from non-cancer causes. In a new study, published Jan. 31 in JAMA Oncology, researchers compared four chemotherapy drugs ...

Diseases, Conditions, Syndromes

First-in-human trial of senolytic drugs encouraging

UT Health San Antonio researchers, collaborating with the Mayo Clinic and the Wake Forest School of Medicine, are the first to publish results on the treatment of a deadly age-related disease in human patients with drugs ...

page 10 from 19